Pelvic and Aortic-cava Lymphadenectomy Randomized Phase III for Advanced Ovarian Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
survival with out recurrence
5 years
No
france : Afssaps
SC 07/12-H
NCT01218490
December 2008
December 2016
Name | Location |
---|